August 24 – virtual event

As a wave of up-and-coming cell and gene therapies eye the path to approval in the near future, a combination of uncertainties threaten the waters ahead. A lack of talent, shortage of manufacturing, standardization and shifting infrastructure are just the beginning of a range of potential issues.

Join Precision ADVANCE and Endpoints News as we kick off Cell & Gene Day, where we’ll convene three expert panels to find out where the field stands today and explore funding, development and launch strategies to smooth out the ride to commercialization.

Click here to find additional details and registration information.

Related Content

Evidence Matters 2022

Evidence Matters 2022

Evidence Matters is a virtual one-day summit that brings the literature review community together from different industries to learn, engage, and solve ever-pressing evidence-based research challenges.